Restorative chemotherapy in degenerative hip disease

Area of Science:

• Orthopedics
• Regenerative Medicine
• Biochemistry

Background:

• Degenerative joint disease (DJD) of the hip is a common condition causing pain and reduced function.
• Current treatments for DJD often provide symptomatic relief but do not address underlying joint degeneration.
• A novel approach using cartilage and bone marrow extract is being investigated for its potential to regenerate joint tissues.

Purpose of the Study:

• To evaluate the efficacy and safety of cartilage and bone marrow extract in treating DJD of the hip.
• To investigate the potential of this extract to promote joint space recovery and femoral head regeneration.
• To explore the underlying mechanisms of action and propose a theory for DJD pathogenesis.

Main Methods:

• A prolonged treatment study involving twenty patients diagnosed with DJD of the hip.
• Administration of a cartilage and bone marrow extract.
• Clinical assessments of pain and function, alongside radiographic evaluations (X-rays) to monitor joint space and bone structure.

Main Results:

• A majority of patients experienced clinical improvements, including reduced joint pain and increased function.
• Four patients demonstrated significant radiographic improvements, showing recovery of joint space and regeneration of the femoral head.
• The treatment exhibited no significant toxicity.

Conclusions:

• Treatment with cartilage and bone marrow extract is a rational and effective therapy for DJD of the hip.
• The extract demonstrates potential for joint regeneration, offering a promising therapeutic option.
• DJD may be a multifactorial disorder, potentially linked to impaired growth hormone processing in the liver.